| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/09/2011 | EP2292613A1 Dihydroindolinone derivatives |
| 03/09/2011 | EP2292609A1 Crystalline forms of rufinamide |
| 03/09/2011 | EP2292595A1 Potassium channel modulators |
| 03/09/2011 | EP2292577A1 (+)-stereoisomer of 2,6-di-sec-butylphenol and analogs thereof |
| 03/09/2011 | EP2292269A2 Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
| 03/09/2011 | EP2292247A2 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 03/09/2011 | EP2292240A1 Use of rapamycin for treatment or prevention of Alzheimer's Disease |
| 03/09/2011 | EP2292239A2 Remedies for diseases to be applied to eye |
| 03/09/2011 | EP2292238A1 Use of Steroids or Glucocorticoids for treatment or prevention of Alzheimer's Disease |
| 03/09/2011 | EP2292237A1 Sigma ligands for the prevention or treatment of pain induced by chemotherapy |
| 03/09/2011 | EP2292236A1 Sigma ligands for the prevention or treatment of pain induced by chemotherapy |
| 03/09/2011 | EP2292235A2 Methotrexate solutions |
| 03/09/2011 | EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II |
| 03/09/2011 | EP2292231A1 Therapeutic agent for spinal canal stenosis |
| 03/09/2011 | EP2292223A1 Polyunsaturated fatty acid supplements |
| 03/09/2011 | EP2292222A1 Polymorphic Forms of a GABAA Agonist |
| 03/09/2011 | EP2292211A2 Mucoadhesive pharmaceutical formulations |
| 03/09/2011 | EP2292210A1 Preparation for the prevention and/or treatment of dementia syndromes |
| 03/09/2011 | EP2292091A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/09/2011 | EP2291521A1 Viral nucleic acid for the treatment of neurodegenerative disorders |
| 03/09/2011 | EP2291405A1 ANTI-PirB ANTIBODIES |
| 03/09/2011 | EP2291383A1 New classes of gabaa/bzr ligands |
| 03/09/2011 | EP2291380A1 Nalmefene prodrugs |
| 03/09/2011 | EP2291352A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway |
| 03/09/2011 | EP2291186A2 Materials and methods for suppressing and/or treating neurofibroma and related tumors |
| 03/09/2011 | EP2291181A2 Psycho-pharmaceuticals |
| 03/09/2011 | EP2291178A2 Controlled release formulations of pramipexole |
| 03/09/2011 | EP2291089A1 Bifidobacterium longum and hippocampal bdnf expression |
| 03/09/2011 | EP2291084A1 Carbonate prodrugs and methods of using the same |
| 03/09/2011 | EP2109615B1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 03/09/2011 | EP2032534B1 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| 03/09/2011 | EP1996194B1 Homotropanes with central nervous system activity |
| 03/09/2011 | EP1912954B1 Novel cysteine protease inhibitors and their therapeutic applications |
| 03/09/2011 | EP1748069B1 Follistatin mutant polypeptide |
| 03/09/2011 | EP1624845B1 4',4''-substituted 3alpha-(diphenylmethoxy)tropane analogs for the treatment of adhd |
| 03/09/2011 | EP1620434B1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 03/09/2011 | EP1575548B1 Compositions and methods for promoting neuronal outgrowth |
| 03/09/2011 | EP1497279B1 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 03/09/2011 | CN101984035A Health wine and preparation method thereof |
| 03/09/2011 | CN101983717A Traditional Chinese medicine for treating migraine |
| 03/09/2011 | CN101983711A Traditional Chinese medicine for treating encephalatrophy |
| 03/09/2011 | CN101983705A Traditional Chinese medicine for treating diabetic acra necrosis |
| 03/09/2011 | CN101983704A Traditional Chinese medicine for treating diabetic foot |
| 03/09/2011 | CN101983696A Traditional Chinese medicine for treating giddy disease |
| 03/09/2011 | CN101983686A Medicament for treating insomnia |
| 03/09/2011 | CN101983673A Traditional Chinese medicine for treating diabetic gastroparesis |
| 03/09/2011 | CN101983671A Traditional Chinese medicine for treating diabetic peripheral neuropathy |
| 03/09/2011 | CN101326163B Prolinamide derivatives as sodium channel modulators |
| 03/09/2011 | CN101263130B 2-苯胺-4-芳基取代的噻唑衍生物 2-anilino-4-aryl-substituted thiazole derivative |
| 03/09/2011 | CN101259193B Medicinal composition for treating angioneurotic headache and preparation thereof |
| 03/09/2011 | CN101230033B New azabicycloalkane derivatives, preparing method and medicament combination containing the same |
| 03/08/2011 | US7902379 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902360 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
| 03/08/2011 | US7902185 Treatment of neurodegenerative diseases using proteasome modulators |
| 03/08/2011 | US7902179 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease |
| 03/08/2011 | US7902164 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/08/2011 | US7902157 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/08/2011 | US7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 03/08/2011 | US7901683 Methods of inhibiting amyloid toxicity |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | CA2689051C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/08/2011 | CA2468691C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2446748C Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| 03/08/2011 | CA2432126C Complex of modafinil and cyclodextrin |
| 03/08/2011 | CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 03/08/2011 | CA2361251C Formulations comprising antisense nucleotides to connexins |
| 03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
| 03/03/2011 | WO2011026153A2 Inotilone derivatives as coherent biological response modifier (cbmr) |
| 03/03/2011 | WO2011026060A2 Treatment and prevention of secondary injury after trauma or damage to the central nervous system |
| 03/03/2011 | WO2011026051A2 Tea based smoking product |
| 03/03/2011 | WO2011025785A1 Methods for the prevention and treatment of cerebral ischemia |
| 03/03/2011 | WO2011025230A2 Gaba release-regulating agent in cerebellum |
| 03/03/2011 | WO2011025121A2 Composition for clearing hangovers using hot-spring water |
| 03/03/2011 | WO2011025120A2 Composition for clearing hangovers and composition for restoring liver function using hot-spring water |
| 03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| 03/03/2011 | WO2011024822A1 Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis |
| 03/03/2011 | WO2011024156A1 Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders |
| 03/03/2011 | WO2011024115A1 Composition and method for treating cognitive impairments in down syndrom subjects |
| 03/03/2011 | WO2011024078A1 3 -oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments |
| 03/03/2011 | WO2011024001A1 Np-1 antagonists and their therapeutic use |
| 03/03/2011 | WO2011023812A1 Microsomal prostaglandin e synthase-1 (mpges1) inhibitors |
| 03/03/2011 | WO2011023796A1 Bifeprunox for treating addiction |
| 03/03/2011 | WO2011023795A1 (thio)morpholine derivatives as s1p modulators |
| 03/03/2011 | WO2011023769A1 Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast |
| 03/03/2011 | WO2011023753A1 Benzoxazine derivatives as glycine transport inhibitors |
| 03/03/2011 | WO2011023733A1 Anhydrate forms of a pyridine derivative |
| 03/03/2011 | WO2011023626A1 Pyrrolidine derivatives as nk3 receptor antagonists |
| 03/03/2011 | WO2011023585A1 Piperidine derivatives used as orexin antagonists |
| 03/03/2011 | WO2011023578A1 5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder |
| 03/03/2011 | WO2011023250A1 Treatment of neurological or neurodegenerative disorders |
| 03/03/2011 | WO2011023249A1 Treatment of neurological of neurodegenerative disorder |
| 03/03/2011 | WO2010145644A3 Composition for transporting orotic acid across the blood-brain barrier |
| 03/03/2011 | WO2010129273A3 Butaclamol for the treatment of amyotrophic lateral sclerosis |
| 03/03/2011 | WO2010123838A3 Novel amide and amidine derivatives and uses thereof |
| 03/03/2011 | WO2010121023A3 Peptides and aptamers for targeting of neuron or nerves |